For the quarter ended March 2025, Stryker (SYK) reported revenue of $5.87 billion, up 11.9% over the same period last year. EPS came in at $2.84, compared to $2.50 in the year-ago quarter. The ...

Shares of Stryker Corp. SYK advanced 1.13% to $378.22 Friday, on what proved to be an all-around favorable trading session ...

Stryker (NYSE:SYK) delivered mixed financial results, with first-quarter 2025 earnings showing increased sales but reduced net income and EPS compared to the previous year. The company's decision to ...

Stryker boosts 2025 sales forecast after strong Q1 results, despite a $200M hit from tariffs on its global medical device ...

Stryker saw year-over-year revenue growth in the first quarter of 2025, according to financial results posted May 2. Six things to know: 1. Quarterly revenue reached $5.9 billion, an 11.9% increase ...

Stryker expects a $200 million hit to its 2025 earnings from tariffs, the latest medical device company to call out impacts ...

Stryker Corp kicked off 2025 with a revenue leap to $5.9 billion, surpassing forecasts thanks to booming MedSurg and ...

Medical technology company Stryker (NYSE:SYK) reported Q1 CY2025 results exceeding the market’s revenue expectations, with sales up 11.9% year on year to $5.87 billion. Its non-GAAP profit of $2.84 ...

Our 2024 momentum continued into the first quarter as we delivered double-digit organic sales growth and continued to expand adjusted operating margins,” said Kevin A. Lobo, Chair and CEO. “We remain ...

The average estimate of 12 analysts surveyed by Zacks Investment Research was for earnings of $2.73 per share. The medical device maker posted revenue of $5.87 billion in the period, also exceeding ...

Stryker Corporation is flexing serious muscle in the evolving healthcare arena, despite rising industry complexities and ...